DOYLESTOWN, Pa., April 8, 2025 — Korio, Inc., the pioneering Randomization & Trial Supply Management (RTSM) technology company, today announced..
Category: News
Korio Introduces Mid-Study RTSM Migration Solution for Sponsors Seeking Vendor Change
Feeling Trapped by your Current RTSM Solution? How to exit your provider with minimal disruption. Doylestown, PA – March..
Korio Secures Series A Funding to Accelerate Growth of Innovative Randomization & Trial Supply Management (RTSM) Platform
Korio to support patient enrollment and randomization for first randomized sub study in the trial.
Korio’s Next-Generation RTSM Platform Selected For The Leukemia & Lymphoma Society’s Beat AML® Master Clinical Trial
Korio to support patient enrollment and randomization for first randomized sub study in the trial.
Korio to Launch IRT Industry’s First Compliance-Centric Platform
Korio to Launch IRT Industry’s First Compliance-Centric Platform Founders Seek to Define New Standard for Excellence in Clinical Trials Doylestown,..